Absorbed dose and biologically effective dose in patients with high-risk non-Hodgkin’s lymphoma treated with high-activity myeloablative 90Y-ibritumomab tiuxetan (Zevalin).
Chiesa C
Eur J Nucl Med Mol Imaging. 2009 May 20;36(11):1745-57. doi: 10.1007/s00259-009-1141-x
Antitumor activity of human CD34+ cells expressing membrane-bound tumor necrosis factor-related apoptosis-inducing ligand.
Carlo-Stella C
Hum Gene Ther. 17(12):1225-40.
Age- and irradiation-associated loss of bone marrow hematopoietic function in mice is reversed by recombinant human growth hormone.
Carlo-Stella C
Exp Hematol. 32(2):171-8.
Amifostine (WR-2721) selective protection against melphalan genotoxicity.
Buschini A
Leukemia. 14(9):1642-51.
Arachidonic acid mediates interleukin-1 and tumor necrosis factor-alpha-induced activation of the c-jun amino-terminal kinases in stromal cells.
Rizzo MT, Carlo-Stella C
Blood. 88(10):3792-800.
Arachidonic acid induces c-jun gene expression in stromal cells stimulated by interleukin-1 and tumor necrosis factor-alpha: evidence for a tyrosine-kinase-dependent process.
Rizzo MT
Blood. 86(8):2967-75.
Autologous transplant for chronic myelogenous leukemia using marrow treated ex vivo with mafosfamide.
Carlo-Stella C
Bone Marrow Transplant. 14(3):425-32.
Acquired cyclic thrombocytopenia-thrombocytosis with periodic defect of platelet function.
Balduini CL
Br J Haematol. 85(4):718-22.
Antiproliferative Effects of 1α-OH-vitD(3) in Malignant Melanoma: Potential Therapeutic implications.
Spath L
Sci Rep. 2017 Jan 11;7:40370. doi: 10.1038/srep40370
Anti-LL37 Antibodies Are Present in Psoriatic Arthritis (PsA) Patients: New Biomarkers in PsA.
Frasca L
Front Immunol. 2018 Sep 12;9:1936. doi: 10.3389/fimmu.2018.01936